Protara Therapeutics Inc

NASDAQ:TARA   3:59:54 PM EDT
6.75
-0.06 (-0.88%)
Products

Protara Therapeutics Announces FDA Clearance Of Investigational New Drug Application For Tara-002 For The Treatment Of Non-Muscle Invasive Bladder Cancer

Published: 10/12/2021 11:33 GMT
Protara Therapeutics Inc (TARA) - Protara Therapeutics Announces FDA Clearance of Investigational New Drug Application for Tara-002 for the Treatment of Non-muscle Invasive Bladder Cancer.
Protara Therapeutics Announces FDA Clearance of Investigational New Drug Application for Tara-002 for the Treatment of Non-muscle Invasive Bladder Cancer.
Protara Therapeutics Announces FDA Clearance of Investigational New Drug Application for Tara-002 for Treatment of Non-muscle Invasive Bladder Cancer.
Protara Therapeutics Inc - Expects to Initiate a Phase 1 Clinical Trial of Tara-002 in Adults With High-grade Nmibc by End of 2021.